Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG)

zzlangerhans (99.78) Submitted: 11/3/2012 1:31:00 AM : Start Price: $4.80 ROSG Score: -47.47

Is it game over for Rosetta? The traders seemed to have moved on after the hype and the dilution, and the share price has been sinking back towards a rational level. Management is still given to making preposterous claims such as a 600M annual market opportunity for miReview mets2, but they've booked some serious cash from dilution which gives them a lifeline. Hopefully they'll use that lifeline to tie some interesting knots in the next few months and I'll be able to play along.

TSIF (99.96) Submitted: 10/11/2012 12:26:32 PM : Start Price: $5.37 ROSG Score: -52.42

Rosetta Genomics LTD is a swing trade in my CAPs world. Along with GENE.
I can call them up or down, but if you are mimicing me, you can miss the swing unless you use limits.

Up call this time. New investors bought around $5. Not always security in a small float, diagnostic company, but some chance of a floor. Buyout rumors, small float, etc, can spike this. It could also go into a long term down trend. Past spikes, trading ranging are no guarntee of history repeating itself.

CAPS Mileage may vary.

New shares issued around $5.00 helped set a floor, but may add liquidity, slowing these erratic, high beta runs. Trade between $5.30 and $6.00. Hit it on either side. May get caught at any given point. NOTE 3 month "estimate". Most likely 7-10 days and back out before this catches a low float, short covering, temporary, but painful, speculating updraft.

phatchips767 (< 20) Submitted: 6/21/2012 12:19:47 PM : Start Price: $13.01 ROSG Score: -98.66

israeli company which is doing well for TSIF.